Although many mechanisms as well as active compounds have been reported, only two classes of drugs, acetylcholinesterase inhibitor (AChEI) and N-methyl-D-aspartate receptor (NMDAR), are clinially available for AD treatment. Here, ACHE is linked to Alzheimer disease.